Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018)

Siga Technologies' (SIGA) quarterly Non-Current Deffered Revenue came in at $376.0 million in Q1 2018, little changed on a YoY basis from $376.2 million in Q1 2017, and little changed quarter-over-quarter from $377.6 million in Q4 2017.

Analysis

Siga Technologies (SIGA) Non-Current Deffered Revenue (2011 - 2018) Analysis & Trends

Siga Technologies (SIGA) has reported Non-Current Deffered Revenue for 8 consecutive years, with $376.0 million the latest figure, recorded in Q1 2018.

  • For the quarter ending Q1 2018, Non-Current Deffered Revenue changed 0.05% year-over-year to $376.0 million; the trailing twelve-month figure through Mar 2018 stood at $376.0 million (changed 0.05% YoY), and the FY2017 full-year result was $377.6 million, up 2.76% from the prior year.
  • Non-Current Deffered Revenue was little changed at $376.0 million in Q1 2018 per SIGA's latest filing, from $377.6 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $377.6 million in Q4 2017 and bottomed at $81799.0 in Q4 2014.
  • Historically, Non-Current Deffered Revenue has averaged $268.5 million across 5 years, with a median of $271.9 million in 2016.
  • The sharpest annual moves came in 2014 and 2015: Non-Current Deffered Revenue plunged 99.95% in 2014, then soared 311955.61% in 2015.
  • Over 5 years, Non-Current Deffered Revenue stood at $81799.0 in 2014, then jumped by 311955.61% to $255.3 million in 2015, then jumped by 43.97% to $367.5 million in 2016, then climbed by 2.76% to $377.6 million in 2017, then slipped by 0.43% to $376.0 million in 2018.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $376.0 million, $377.6 million, and $377.4 million for Q1 2018, Q4 2017, and Q3 2017 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Siga Technologies 220.19 Mn 65.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 376.03 Mn
Dec 31, 2017 377.64 Mn
Sep 30, 2017 377.45 Mn
Jun 30, 2017 376.48 Mn
Mar 31, 2017 376.20 Mn
Dec 31, 2016 367.48 Mn
Sep 30, 2016 367.12 Mn
Jun 30, 2016 288.29 Mn
Mar 31, 2016 255.47 Mn
Dec 31, 2015 255.26 Mn
Sep 30, 2015 255.09 Mn
Jun 30, 2015 233.74 Mn
Mar 31, 2015 13.53 Mn
Dec 31, 2014 81,799.00
Jun 30, 2014 188.08 Mn
Mar 31, 2014 187.78 Mn
Dec 31, 2013 162.22 Mn
Sep 30, 2013 162.06 Mn
Jun 30, 2013 119.07 Mn
Mar 31, 2013 83.51 Mn